PATIENT INFORMATION LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE TAKING CIPROXIN SUSPENSION

Size: px
Start display at page:

Download "PATIENT INFORMATION LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE TAKING CIPROXIN SUSPENSION"

Transcription

1 PATIENT INFORMATION LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE TAKING CIPROXIN SUSPENSION CIPROXIN SUSPENSION Ciprofloxacin What does Ciproxin Suspension contain? Each 5ml spoonful of product contains 250mg of the active ingredient ciprofloxacin. Ciproxin Suspension also contains copolymer of ethyl acrylate and methyl methacrylate, magnesium stearate, hypromellose, polysorbate 20, polyvidone 25, lecithin, medium chain triglycerides, sucrose, purified water and strawberry flavours. The suspension is available in bottles containing 100ml of ready-to-use product. The ciprofloxacin contained in Ciproxin is one of a group of antibiotics called quinolones which work by killing bacteria that cause infections. Product Licence Holder: Manufacturer: Bayer plc Pharmaceutical Division Bayer House Strawberry Hill Newbury Berkshire RG14 1JA Bayer S.p.A. Garbagnate Milanese Italy Why have I been prescribed Ciproxin Suspension by my doctor? Ciproxin Suspension has been prescribed by your doctor to treat your bacterial infection. Some of the infections which Ciproxin can be used to treat are: - Chest infections, e.g. bronchitis. Infections of the urinary tract, e.g. cystitis. Intestinal infections, e.g. infective diarrhoea. Anthrax This medicine can also be used if you are five years or older, have cystic fibrosis and get a respiratory tract (lung) infection caused by a bacteria called P. aeruginosa. When should I not take Ciproxin Suspension? Do not take Ciproxin Suspension if you have previously had an allergic reaction to the active ingredient ciprofloxacin or any other quinolone antibiotics. If you are unsure about this, ask your doctor. CIPROXIN/CIPROXIN SUSPENSION/PIL/Approved/UK/PIL CipSusp UK008.DOC (8/) 1

2 Generally, with the exception of the treatment of a lung infection in patients with cystic fibrosis or for the treatment of anthrax, Ciproxin should not be given to children and adolescents unless considered essential by a doctor. As with other antibiotics in this group, Ciproxin may cause pain and swelling in the developing joints of these patients. In particular, Ciproxin Suspension should not be given to children of less than two years of age. What special precautions should I take? If you are pregnant, planning a family or breast-feeding, tell your doctor before taking Ciproxin as it is not recommended for use under these conditions. If you have already informed your doctor, follow his/her instructions carefully. Providing you do not have a problem with your heart or kidneys, you should drink plenty of liquid whilst taking Ciproxin. Ciproxin may cause a problem with your kidneys called "crystalluria" which results in tiny crystals forming in the urine. These crystals cannot be seen by the naked eye. Drinking plenty of liquid can help prevent this occurring. However, if you experience a new pain or discomfort when passing urine whilst you are taking Ciproxin, tell your doctor. If you have a problem with your kidneys, tell your doctor before taking Ciproxin. Your doctor may wish to change your dose to allow for any reduced kidney function. If you have had previous problems with your liver, tell your doctor before treatment with ciprofloxacin begins. Your doctor may wish to check for any changes in its function. Also consult your doctor if you have yellowing of the whites of the eyes or skin. If you have previously had "fits" or suffer from epilepsy or if you have ever suffered other conditions related to the nervous supply to the brain, tell your doctor before you are given Ciproxin. You may feel depressed, anxious or confused whilst taking your medicine. If any of these progress to you actually physically harming or wanting to physically harm yourself you should stop taking your medicine immediately and consult your doctor. Ciproxin may make you feel less alert, particularly when taken with alcohol. Therefore, make sure you know how you react to Ciproxin before you drive or operate machinery. If in doubt, consult your doctor. If you have a family history of or know that you have the hereditary condition G6PD deficiency, remind your doctor before taking Ciproxin. This condition causes a deficiency of certain chemicals in the red blood cells and, if Ciproxin is taken, it may lead to the breaking down of red blood cells resulting in anaemia and yellowing of the skin (jaundice). Ciproxin may occasionally cause pain and inflammation around your tendons particularly if you are elderly or taking one of a group of medicines called steroids such as hydrocortisone. If you experience these symptoms, seek medical advice immediately and rest the affected limb. Do not take the next dose of Ciproxin Suspension unless your doctor tells you to do so. If you develop severe and persistent diarrhoea which may contain blood and mucus whilst you are taking your suspension, or after stopping your suspension, you should consult your doctor immediately as you may be suffering from the condition pseudomembranous colitis which can sometimes be life-threatening. CIPROXIN/CIPROXIN SUSPENSION/PIL/Approved/UK/PIL CipSusp UK008.DOC (8/) 2

3 This medicine may make your skin become more sensitive to sunlight or UV light. You should avoid exposure to strong sunlight and should not use a sun-bed or other means of UV exposure. Certain medicines are known to affect the action of Ciproxin and are best avoided whilst taking it. Therefore, ask your doctor for advice if you wish to take antacids for indigestion, any other preparations containing aluminium, calcium, magnesium or iron or highly buffered drugs such as didanosine whilst taking Ciproxin. If these preparations are essential, they must not be taken within four hours of taking Ciproxin Suspension. This is because if taken within this time period, they will affect the absorption of Ciproxin Suspension into your body, decreasing the amount available to treat your infection. If you take multivitamins or minerals, check that they do not contain iron, calcium or magnesium. If they do, your doctor may want you to stop taking them whilst you are taking Ciproxin. Remind your doctor if you are taking drugs that thin the blood (anticoagulants) such as warfarin, or any medicines used to relieve pain and inflammation (e.g. fenbufen), except for aspirin. If you are taking glibenclamide for diabetes, remind your doctor as Ciproxin sometimes increases the ability of glibenclamide to lower blood sugar and may result in hypoglycaemia (i.e. feeling cold, dizzy, confused, or a headache due to a lack of blood sugar). Remind your doctor if you are taking probenecid or metoclopramide as these drugs may affect the level of Ciproxin in your blood. If you are taking cyclosporin at the same time as Ciproxin, your doctor may want to take regular blood samples to monitor the level of a substance called creatinine in your blood. If you are taking phenytoin for epilepsy, remind your doctor as the levels of this medicine may be altered if used at the same time as Ciproxin. If you are taking methotrexate at the same time as Ciproxin, remind your doctor as he/she may want to do additional blood tests. If you take theophylline for asthma, remind your doctor as he/she should monitor the level of theophylline in your blood. This is particularly important if you suffer from "fits" or convulsions. High levels of theophylline in the blood may be life-threatening. If you go into hospital for surgery, have dental treatment which requires an anaesthetic or you need to provide a blood or urine sample, tell the doctor or dentist that you are taking Ciproxin Suspension. When and how do I take Ciproxin Suspension? The dosage of Ciproxin Suspension required and the duration of treatment depends upon the severity and type of your infection. The usual dosage is from 250mg to 750mg twice daily. For the treatment of a lung infection in cystic fibrosis patients (aged 5-17 years), a dose of 20mg/kg orally twice daily. (The maximum daily dose is 1500 mg.) For the treatment of anthrax in children, a dose of 15mg/kg twice daily (the maximum daily dose is 1000mg). CIPROXIN/CIPROXIN SUSPENSION/PIL/Approved/UK/PIL CipSusp UK008.DOC (8/) 3

4 This product may also be used in adolescents and children for the treatment of other infections if the doctor considers it essential. The usual dose in these cases is 4-8mg/kg iv twice daily or 5-15 mg/kg orally twice daily. The exact dosage depends on the severity of the infection. Take the suspension as prescribed by your doctor. Usually this will be one to three spoonfuls taken twice daily. In order to get the correct dose, it is important to use the measuring spoon provided. A spoonful (5ml) is measured by pouring the suspension into the spoon up to the line marked 1/1. Before each dose, the bottle must be shaken vigorously for approximately 15 seconds. The suspension should be swallowed whole and the granules should not be chewed. A glass of water may be taken after dosing. Ensure you reclose the bottle according to the instructions on the cap. Drink several more glasses of water during every day of your treatment, unless told otherwise by your doctor. If you are taking Ciproxin Suspension on an empty stomach, do not eat or drink dairy products (such as milk or yoghurt) or drinks with added calcium at the same time as the suspension Take the suspension for as long as directed by your doctor. The usual duration of treatment is between three and 10 days, but it may be longer if your infection is more persistent or severe. It is important that you complete the course of treatment, even if you begin to feel better after a few days. If you stop taking this medicine too soon, your infection may return and the bacteria responsible for your symptoms may become resistant to Ciproxin. This means that your medicine will no longer be able to work in treating your bacterial infection. The duration of treatment for a lung infection in children or adolescents with cystic fibrosis is days. The duration of treatment in patients with anthrax is 60 days. DO NOT EXCEED THE PRESCRIBED DOSE If you take more than the prescribed dose, or in the event of an overdose, seek medical advice immediately and, if possible, take the bottle of suspension or the box with you to show the doctor. What should I do if I forget to take my Ciproxin Suspension? Take your normal dose as soon as possible and then continue as prescribed. However, if it is almost time for your next dose, do not take the missed dose and continue as usual, making sure that you complete your course of treatment. What side-effects may I experience? As can happen with some antibiotics, certain side-effects have been reported after Ciproxin. You may experience diarrhoea, feeling sick (nausea) and skin rashes. As with all medicines, some people may be allergic to Ciproxin. Usually, if you are allergic to Ciproxin, a reaction will occur soon after you start taking the suspension. An allergic reaction can appear as a rash, hives, itching, small red spots on the skin or a fever. Very rarely, an allergy to Ciproxin can cause facial swelling, swelling of the blood vessels in the skin and CIPROXIN/CIPROXIN SUSPENSION/PIL/Approved/UK/PIL CipSusp UK008.DOC (8/) 4

5 severe skin reactions such as large fluid-filled blisters, sores and ulceration and shortness of breath. Ulceration can also occur in the mouth and throat, around the anus and genital region and on the surface of the eyes. These symptoms are often accompanied by sickness, headache and fever. If you experience any of these symptoms, stop the treatment and seek medical advice immediately. The skin of some people may become more sensitive to the sun whilst taking Ciproxin. You may experience thrush, a general feeling of being unwell or feel unsteady when walking. Ciproxin may make you hyperglycaemic, that is have high levels of the sugar glucose in your blood. If you feel unwell, have an increased need to pass water or drink more than usual, consult your doctor who can test for this condition. Rarely, you may experience pain, pain in your fingers and/or toes, chest pain or back pain. Rarely, you may experience inflammation in the blood vessels of the skin. You may experience a headache, dizziness, restlessness and either an increased or a decreased sensitivity to touch. If you experience "fits", trembling, a tingling sensation, hallucinations, very severe headaches with visual disturbances, increased sleepiness, sleep disorders or feel anxious, confused or depressed which may progress to you actually physically harming or wanting to physically harm yourself, or you feel unsteady when walking, consult your doctor as soon as possible. Ciproxin may cause vomiting, indigestion, stomach-ache, wind, difficulty in swallowing, loss of appetite. Rarely, a disorder called pseudomembranous colitis can occur which causes attacks of diarrhoea, which may contain blood and mucus. Consult your doctor immediately if this occurs. You may experience a fast heartbeat, fainting, hot flushes, lowered blood pressure, sweating, swelling of the face or limbs whilst taking Ciproxin Suspension. Ciproxin may affect certain components in the blood. This may lead to bruising, jaundice, a persistent sore throat, fever with tiredness or a general feeling of being unwell, which may be due to anaemia. In some cases this may be life-threatening. Ciproxin may cause joint or tendon swelling with pain which may lead to tendon rupture especially of the large tendon at the back of the ankle. If you experience these symptoms, seek medical advice immediately and rest the affected limb. Do not take the next dose of Ciproxin Suspension unless your doctor tells you to. Ciproxin can also cause muscle pain, increased muscle tone, weakness or twitching. If you suffer from the medical condition myasthenia gravis (a rare disorder of the nervous system), taking Ciproxin may rarely, make the symptoms of your disease become worse. If you think you are affected consult your doctor. Ciproxin has been known to cause effects on the liver such as inflammation (hepatitis) and yellow jaundice which may rarely progress to life-threatening hepatic failure. It may cause inflammation of the pancreas, which may lead to severe pain in the upper abdomen or back. It may also cause effects on the kidney which lead to pain and discomfort when passing water (crystalluria) or blood in the urine. If you notice yellowing of your skin or any change in your urine output or appearance, possibly accompanied by kidney pain, or pain in your abdomen or back, seek medical advice immediately. CIPROXIN/CIPROXIN SUSPENSION/PIL/Approved/UK/PIL CipSusp UK008.DOC (8/) 5

6 Rarely, people have experienced visual disturbances including blurred or double vision and colour vision disturbances, ringing in the ears and, sometimes, impaired hearing which returns to normal once treatment with Ciproxin finishes. Impaired sense of taste and smell have also been reported; these usually return to normal once treatment with Ciproxin finishes. IF YOU EXPERIENCE ANY OF THESE EFFECTS OR ANY OTHER UNDESIRABLE EFFECTS, TELL YOUR DOCTOR IMMEDIATELY. YOUR DOCTOR WILL GIVE YOU ADVICE. How should I store my Ciproxin Suspension? Ciproxin Suspension should be stored in the original box avoiding inverted storage, and in a cool, dry place. Ciproxin Suspension may be stored in a refrigerator (2-8 C), but ensure that it does not freeze. The ready-to-use product should be kept for a maximum of 14 days. KEEP ALL MEDICINES OUT OF THE REACH OF CHILDREN Do not use the suspension after the expiry date which is marked on the label of the bottle and on the outer carton. If you find that you have kept the suspension after its expiry date, or some is left in the bottle after your course of treatment, return it to your local pharmacist (chemist) who will dispose of it properly. Date of Preparation of Leaflet: June 2003 REMEMBER: This medicine has been prescribed for you. Do not give it to anyone else under any circumstances, even if they have the same condition as you. If you have any doubts about taking Ciproxin Suspension correctly, seek the advice of your doctor or pharmacist. Product Licence Number: PL 0010/0211 CIPROXIN/CIPROXIN SUSPENSION/PIL/Approved/UK/PIL CipSusp UK008.DOC (8/) 6

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC. SCHEDULING STATUS: S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNAFLOC 250 (tablets) DYNAFLOC 500 (tablets) DYNAFLOC 750 (tablets) Read this entire leaflet carefully before you start taking

More information

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS (tablets) POLLENTYME S (syrup) Read all of this leaflet carefully because it contains important information

More information

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS PROPOSED FINAL PATIENT INFORMATION LEAFLET FOR POLLENTYME TABLETS & POLLENTYME S PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS

More information

Ceclor CD cefaclor monohydrate sustained release tablets

Ceclor CD cefaclor monohydrate sustained release tablets Ceclor CD cefaclor monohydrate sustained release tablets Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Ceclor CD. It does not contain all

More information

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules. Clindamycin hydrochloride Capsules 150 mg What is in this leaflet Consumer Medicine Information TOPICIL Please read this leaflet carefully before you start using Topicil Capsules. This leaflet answers

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.

More information

HERNOVIR 200 mg tablets

HERNOVIR 200 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen Sugar Free 125mg/5ml and 250mg/5ml Powder for Oral Solution Phenoxymethylpenicillin Read all of this leaflet carefully before you start taking this medicine

More information

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any

More information

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline Package leaflet: Information for the patient Lymelysal 300 mg hard capsules lymecycline equivalent to 300 mg tetracycline Read all of this leaflet carefully before you start taking this medicine because

More information

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET AMLOC RANGE SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it

More information

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

Bicillin L-A Benzathine benzylpenicillin tetrahydrate Bicillin L-A Benzathine benzylpenicillin tetrahydrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Bicillin L- A. It does not contain all the available

More information

PATIENT INFORMATION LEAFLET CARZIN XL

PATIENT INFORMATION LEAFLET CARZIN XL SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: 4 mg film coated tablets. Read all of this leaflet carefully before you start taking. Keep this leaflet. You may need to read it

More information

PATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin

PATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin PATIENT INFORMATION LEAFLET ZITHROMAX 250mg Capsules azithromycin Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you have

More information

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM. 1 Consumer Medicine Information Flecainide acetate Tablets 50 mg & 100 mg What is in this leaflet Please read this leaflet carefully before you start taking. This leaflet answers some common questions

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

Bonefos 400 mg capsules sodium clodronate

Bonefos 400 mg capsules sodium clodronate Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end

More information

BACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR

BACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER BACTRIM tablets CO-TRIMOXAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

Persantin SR. What is in this leaflet. 200 mg capsules. Dipyridamole. Consumer Medicine Information

Persantin SR. What is in this leaflet. 200 mg capsules. Dipyridamole. Consumer Medicine Information Persantin SR 200 mg capsules Dipyridamole Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Persantin SR. It does not contain all the available information.

More information

Cosudex. Bicalutamide 50 mg Tablets CONSUMER MEDICINE INFORMATION

Cosudex. Bicalutamide 50 mg Tablets CONSUMER MEDICINE INFORMATION Cosudex Bicalutamide 50 mg Tablets CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some of the common questions people ask about Cosudex. It does not contain all the information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Glimbax (600 mg film-coated tablets) (Prulifloxacin) Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

This leaflet answers some common questions about ATIVAN. It does not contain all of the available information.

This leaflet answers some common questions about ATIVAN. It does not contain all of the available information. Ativan Lorazepam Tablets Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ATIVAN. It does not contain all of the available information. It does not

More information

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base) Package leaflet: Information for the user Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base) Read all of this leaflet carefully before you start taking this medicine because

More information

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET PROPOSED PATIENT INFORMATION LEAFLET FOR PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PHARMA DYNAMICS CLOPIDOGREL

More information

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

KAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR

KAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER KAMIREN 2 mg, 4 mg TABLETS DOXAZOSIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid) PATIENT INFORMATION LEAFLET Nu-Seals 75 aspirin (acetylsalicylic acid) Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you

More information

Eloxatin Oxaliplatin concentrated solution for injection

Eloxatin Oxaliplatin concentrated solution for injection Eloxatin Oxaliplatin concentrated solution for injection Consumer Medicine Information Please read this leaflet before you are given this medicine. What is in this leaflet This leaflet answers some common

More information

2 What you need to know before you take Zantac

2 What you need to know before you take Zantac Package leaflet: Information for the user Zantac Tablets 150 mg and 300 mg ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

CONSUMER MEDICINE INFORMATION ARROW - NORFLOXACIN

CONSUMER MEDICINE INFORMATION ARROW - NORFLOXACIN CONSUMER MEDICINE INFORMATION ARROW - NORFLOXACIN Norfloxacin 400 mg Tablets What is in this leaflet This leaflet answers some common questions about ARROW - NORFLOXACIN. It does not contain all of the

More information

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

SANDOMIGRAN. 0.5mg tablet Pizotifen malate SANDOMIGRAN 0.5mg tablet Pizotifen malate What is in this leaflet This leaflet answers some common questions about Sandomigran. It does not contain all the available information. It does not take the place

More information

CIPROXIN HC Ear Drops

CIPROXIN HC Ear Drops CIPROXIN HC Ear Drops Ciprofloxacin and Hydrocortisone CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you use. This leaflet answers some common questions

More information

APOHEALTH Diarrhoea Relief PLUS

APOHEALTH Diarrhoea Relief PLUS APOHEALTH Diarrhoea Relief PLUS Chewable Tablets Contains the active ingredient Loperamide hydrochloride and Simethicone Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate) PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN 1 mg/5 ml Oral Solution Ketotifen (as Ketotifen hydrogen fumarate) Read all of this leaflet carefully because it contains important information for you.

More information

Onglyza CONSUMER MEDICINE INFORMATION

Onglyza CONSUMER MEDICINE INFORMATION What is in this leaflet Onglyza Saxagliptin 2.5 mg and 5 mg film coated tablets CONSUMER MEDICINE INFORMATION This leaflet answers some of the common questions people ask about Onglyza. It does not contain

More information

PATIENT INFORMATION LEAFLET TEXAMER

PATIENT INFORMATION LEAFLET TEXAMER SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: film-coated tablets Read all of this leaflet carefully because it contains important information for you. is available without a doctor s prescription,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available

More information

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic 0 PRODUCT MONOGRAPH FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION Anti-inflammatory, Analgesic INFORMATION FOR THE PATIENT FLOCTAFENINE, which has been prescribed to you

More information

XYZAL 5 MG FILM-COATED TABLET

XYZAL 5 MG FILM-COATED TABLET XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg/5 ml Oral Suspension fusidic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PATIENT INFORMATION LEAFLET DYNARB RANGE

PATIENT INFORMATION LEAFLET DYNARB RANGE SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNARB 75 mg tablets DYNARB 150 mg tablets DYNARB 300 mg tablets Read all of this leaflet carefully before you start taking DYNARB.

More information

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: SCHEDULING STATUS: S2 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: TEXA 10 mg (tablets) TEXA SYRUP (syrup) Read this entire leaflet carefully before you start taking TEXA. Keep this leaflet. You

More information

AMCLAVOX DUO 500/125 & AMCLAVOX DUO FORTE 875/125 TABLETS. You may need to read it again. DUO & AMCLAVOX DUO FORTE tablets used for?

AMCLAVOX DUO 500/125 & AMCLAVOX DUO FORTE 875/125 TABLETS. You may need to read it again. DUO & AMCLAVOX DUO FORTE tablets used for? 500/125 & FORTE 875/125 TABLETS Amoxicillin and clavulanic acid CONSUMER MEDICINE INFORMATION What is in this leaflet? Please read this leaflet carefully before you take & This leaflet answers some common

More information

Simplotan* tablets Tinidazole (tin-id-azole)

Simplotan* tablets Tinidazole (tin-id-azole) Simplotan* tablets Tinidazole (tin-id-azole) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Simplotan. It does not contain all the available information.

More information

IMIPENEM+CILASTATIN RBX

IMIPENEM+CILASTATIN RBX IMIPENEM+CILASTATIN RBX imipenem/cilastatin sodium 500 mg/500 mg Powder for Solution for Infusion What is in this leaflet This leaflet answers some common questions about IMIPENEM+CILASTATIN RBX. It does

More information

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have. Triprim Tablets Trimethoprim Tablets Consumer Medicine Information What is in this leaflet? The leaflet answers some common questions about Triprim tablets. It does not contain all the available information

More information

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide Package leaflet: Information for the user Flutamid Stada 250 mg tablets Flutamide Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

How it works. Use in children

How it works. Use in children GenRx Allopurinol contains the active ingredient, (al-oe-pur-in-ol) For a copy of a large print leaflet, Ph: 1800 195 055 Consumer Medicine Information What is in this leaflet Read this leaflet carefully

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam) PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

This leaflet answers some common questions about GLUCOBAY tablets. It does not take the place of talking to your doctor or pharmacist.

This leaflet answers some common questions about GLUCOBAY tablets. It does not take the place of talking to your doctor or pharmacist. GLUCOBAY acarbose tablets 50mg and 100mg WHAT IS IN THIS LEAFLET This leaflet answers some common questions about GLUCOBAY tablets. It does not take the place of talking to your doctor or pharmacist. All

More information

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this

More information

Irbenida H 150mg/12,5mg film-coated tablets

Irbenida H 150mg/12,5mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida H 150mg/12,5mg film-coated tablets IRBESARTAN/HYDROCHLOROTHIAZIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Proquin Ciprofloxacin (sip-roe-flox-a-sin)

Proquin Ciprofloxacin (sip-roe-flox-a-sin) Proquin Ciprofloxacin (sip-roe-flox-a-sin) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Proquin. It does not contain all of the available information.

More information

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. STILNOX zolpidem tartrate Consumer Medicine Information WARNING: ZOLPIDEM MAY BE ASSOCIATED WITH UNUSUAL AND POTENTIALLY DANGEROUS BEHAVIOURS WHILST APPARENTLY ASLEEP. THESE HAVE INCLUDED SLEEP WALKING,

More information

What is in this leaflet

What is in this leaflet 1 Consumer Medicine Information Tranexamic acid Film coated tablets, 500 mg What is in this leaflet Please read this leaflet carefully before you start taking. This leaflet answers some common questions

More information

Some general information on hepatitis A infection is given at the end of this leaflet.

Some general information on hepatitis A infection is given at the end of this leaflet. Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT AMOXICILLIN 3G SACHET SUGAR FREE

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT AMOXICILLIN 3G SACHET SUGAR FREE PACKAGE LEAFLET: INFORMATION FOR THE PATIENT AMOXICILLIN 3G SACHET SUGAR FREE Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets Pizotifen (as malate) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION Arrow - Tramadol Tramadol 50 mg capsules What is in this leaflet This leaflet answers some common questions about ARROW - TRAMADOL. It does not contain all of the available

More information

Consumer Medicine Information

Consumer Medicine Information Consumer Medicine Information Trade Name: ZOLPIDEM-DP Active Ingredient: Zolpidem tartrate Warning: Zolpidem may be associated with unusual and potentially dangerous behaviours whilst apparently asleep.

More information

ATORIS 10, 20, 40 mg film-coated tablets

ATORIS 10, 20, 40 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER ATORIS 10, 20, 40 mg film-coated tablets ATORVASTATIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

SULFASALAZIN 500mg enteric-coated tablets

SULFASALAZIN 500mg enteric-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SULFASALAZIN 500mg enteric-coated tablets SULFASALAZINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a

More information

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) PACKAGE LEAFLET Package leaflet: Information for the user Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) Read all of this leaflet carefully before you start taking this medicine because

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr BACLOFEN Baclofen Tablets 10 mg and 20 mg This leaflet is part III of a three-part "Product Monograph" published when BACLOFEN was approved for sale in Canada and is designed

More information

Package leaflet: Information for the user. Zantac Syrup ranitidine hydrochloride

Package leaflet: Information for the user. Zantac Syrup ranitidine hydrochloride Package leaflet: Information for the user Zantac Syrup ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

AMOXYCILLIN SANDOZ Amoxycillin Trihydrate capsules and suspension

AMOXYCILLIN SANDOZ Amoxycillin Trihydrate capsules and suspension Amoxycillin Trihydrate capsules and suspension Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some common questions about It does not contain all the available information.

More information

Package leaflet: Information for the user. Therimin Skogsbär 500 mg Powder for Oral Solution Paracetamol

Package leaflet: Information for the user. Therimin Skogsbär 500 mg Powder for Oral Solution Paracetamol Package leaflet: Information for the user Therimin Skogsbär 500 mg Powder for Oral Solution Paracetamol Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

AUGMENTIN is also used to prevent infection from major surgery.

AUGMENTIN is also used to prevent infection from major surgery. Injection Potassium clavulanate/amoxicillin sodium equivalent to 100 mg clavulanic acid/500 mg amoxicillin Potassium clavulanate/amoxicillin sodium equivalent to 200 mg clavulanic acid/1 g amoxicillin

More information

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read

More information

Package leaflet: Information for the patient. ROBAXIN mg Film-coated tablets for oral use Methocarbamol. 100 Tablets

Package leaflet: Information for the patient. ROBAXIN mg Film-coated tablets for oral use Methocarbamol. 100 Tablets Package leaflet: Information for the patient ROBAXIN - 750 750 mg Film-coated tablets for oral use Methocarbamol 100 Tablets Dosage: 2 tablets to be swallowed 4 times a day or as directed by your doctor.

More information

of LDL and HDL cholesterol.

of LDL and HDL cholesterol. Ezetimibe Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. It does not take the place of talking

More information

LISINOPRIL-GA tablets 2.5 mg, 5 mg, 10 mg, 20 mg. Lisinopril dihydrate

LISINOPRIL-GA tablets 2.5 mg, 5 mg, 10 mg, 20 mg. Lisinopril dihydrate LISINOPRIL-GA tablets 2.5 mg, 5 mg, 10 mg, 20 mg. Lisinopril dihydrate WHAT IS IN THIS LEAFLET This leaflet answers some common questions about LISINOPRIL-GA. It does not contain all the available information.

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) Pfizer Logo Read all of this leaflet carefully before you start taking this

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Aciclovir 400 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this

More information

VACLOVIR. What is in this leaflet. What VACLOVIR is used for. for Herpes Zoster and Herpes Labialis valaciclovir (as hydrochloride)

VACLOVIR. What is in this leaflet. What VACLOVIR is used for. for Herpes Zoster and Herpes Labialis valaciclovir (as hydrochloride) VACLOVIR for Herpes Zoster and Herpes Labialis valaciclovir (as hydrochloride) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VACLOVIR. It does not

More information

PATIENT INFORMATION LEAFLET SINTAIR RANGE

PATIENT INFORMATION LEAFLET SINTAIR RANGE SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: SINTAIR 4 mg (chewable tablets) SINTAIR 5 mg (chewable tablets) SINTAIR 10 mg (tablets) Please read this leaflet carefully before

More information

Consumer Medicine Information

Consumer Medicine Information MAXOLON Consumer Medicine Information Metoclopramide hydrochloride 10mg Tablet What is in this leaflet This leaflet answers some common questions about Maxolon. It does not contain all the available information.

More information

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Package leaflet: Information for the patient Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)

More information

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole.

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole. PHARMACOR OMEPRAZOLE CAPSULES Omeprazole Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about Pharmacor Omeprazole. It does not contain

More information

All medicines have risks and benefits. Your doctor has weighed the possible risks of using SALOFALK against the expected benefits.

All medicines have risks and benefits. Your doctor has weighed the possible risks of using SALOFALK against the expected benefits. SALOFALK enema mesalazine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SALOFALK. It does not contain all of the available information. Reading

More information

GenRx Norfloxacin. What is in this leaflet. Before you take it. What norfloxacin is used for. contains the active ingredient, norfloxacin

GenRx Norfloxacin. What is in this leaflet. Before you take it. What norfloxacin is used for. contains the active ingredient, norfloxacin contains the active ingredient, norfloxacin Consumer Medicine Information For a copy of a large print leaflet Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before taking your medicine

More information

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

BISOLVON Chesty Forte.

BISOLVON Chesty Forte. New Zealand Consumer Medicine Information BISOLVON Chesty Forte Tablets 8 mg Bromhexine hydrochloride What is in this leaflet This leaflet answers some common questions about BISOLVON Chesty Forte. It

More information

NORVASC 5 mg and 10 mg tablets

NORVASC 5 mg and 10 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg Tablets sodium fusidate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide Package leaflet: Information for the user Burinex 5 mg Tablets bumetanide Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep

More information

METHYLDOPA 250 mg Film-coated Tablets

METHYLDOPA 250 mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

ZOLPIDEM PHARMACOR Zolpidem tartrate

ZOLPIDEM PHARMACOR Zolpidem tartrate Zolpidem tartrate Consumer Medicine Information Warning: Zolpidem may be associated with unusual and potentially dangerous behavior whilst apparently asleep. These have included sleep walking, driving

More information

Consumer Medicine Information

Consumer Medicine Information BICALOX Consumer Medicine Information Bicalutamide 50 mg tablets What is in this leaflet This leaflet answers some of the common questions people ask about BICALOX. It does not contain all the information

More information

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Otezla (apremilast) film coated tablets

Otezla (apremilast) film coated tablets New Zealand Consumer Medicine Information Otezla (apremilast) film coated tablets WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Otezla. It does not contain all the available

More information